Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery

Recruiting now

Conditions studied: VV-ECMO, Thoracic Surgery, Emergency Surgery, ARDS, Retrospective Cohort, Propensity Score Matching, Mortality, ECMO Outcomes

In brief

Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).

Key facts

Study ID

NCT07016685

Run by

Centre Hospitalier Universitaire, Amiens

People needed

380

Starts

2025-06-01

Expected to finish

2026-04-01

Last updated by the study team

2025-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ≥ 18 years
• VV-ECMO initiated during or after emergency thoracic surgery
• No opposition to data use

You may not qualify if…

• Pregnant women
• Veno-Arterial ECMO patients
• Patients under legal protection

Where it is running

• CHRU Amiens — Amiens, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.